Trademark: 88920686
Word
XTINDUBEC
Status
Pending
Status Code
734
Status Date
Friday, February 23, 2024
Serial Number
88920686
Mark Type
4000
Filing Date
Monday, May 18, 2020
Published for Opposition
Tuesday, July 27, 2021

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Trademark Events
Feb 24, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2024
Sou Extension 5 Granted
Feb 7, 2024
Sou Extension 5 Filed
Feb 23, 2024
Case Assigned To Intent To Use Paralegal
Feb 7, 2024
Sou Teas Extension Received
Sep 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 15, 2023
Sou Extension 4 Granted
Sep 15, 2023
Sou Extension 4 Filed
Sep 15, 2023
Sou Teas Extension Received
Mar 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2023
Sou Extension 3 Granted
Mar 13, 2023
Sou Extension 3 Filed
Mar 13, 2023
Sou Teas Extension Received
Aug 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2022
Sou Extension 2 Granted
Aug 23, 2022
Sou Extension 2 Filed
Aug 23, 2022
Sou Teas Extension Received
Mar 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2022
Sou Extension 1 Granted
Mar 7, 2022
Sou Extension 1 Filed
Mar 7, 2022
Sou Teas Extension Received
Sep 21, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 27, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 27, 2021
Published For Opposition
Jul 7, 2021
Notification Of Notice Of Publication E-Mailed
Jun 19, 2021
Approved For Pub - Principal Register
Jun 7, 2021
Teas/Email Correspondence Entered
Jun 7, 2021
Correspondence Received In Law Office
Jun 3, 2021
Assigned To Lie
Mar 5, 2021
Notice Of Revival - E-Mailed
Mar 5, 2021
Teas Response To Office Action Received
Mar 5, 2021
Petition To Revive-Granted
Mar 5, 2021
Teas Petition To Revive Received
Mar 1, 2021
Abandonment Notice E-Mailed - Failure To Respond
Feb 27, 2021
Abandonment - Failure To Respond Or Late Response
Aug 15, 2020
Notification Of Non-Final Action E-Mailed
Aug 15, 2020
Non-Final Action E-Mailed
Aug 15, 2020
Non-Final Action Written
Aug 15, 2020
Assigned To Examiner
Jun 2, 2020
New Application Office Supplied Data Entered
May 21, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24